HyBryte™ by Soligenix: Transforming Cutaneous T-Cell Lymphoma Treatment
Soligenix (NASDAQ: SNGX) is a late-stage biopharmaceutical company specializing in developing and commercializing products to treat rare diseases with unmet medical needs. The Company's primary focus is on its Specialized BioTherapeutics business segment, which is responsible for the development of HyBryte™, a novel photodynamic therapy that uses safe visible light for the treatment of cutaneous T-cell lymphoma (CTCL). The Company has successfully completed a Phase 3 study for HyBryte™ and is now negotiating a confirmatory Phase 3 pivotal study design with the US Food & Drug Administration, while also evaluating/pursuing potential HyBryte™ marketing approval ex-U.S. with the successfully completed Phase 3 study. Visit SNGXinfo.com to learn more.
-
4:07
ParisDemers
19 hours agoThe Secret Of How Andrew Tate Got HUGE While In Prison (Full Workout)
7.05K3 -
1:39
Maicy Renee
19 hours agoYou Know What Day It Is!
10.4K2 -
7:00
thehomemender
18 hours agoHow to replace bathroom exhaust fan, easy! The Home Mender
8.44K1 -
22:34
The Bitcoin Family
1 day agoIS THE BITCOIN BULL MARKET OVER??? WATCH ASAP!!!
9.41K3 -
13:31
ROSE UNPLUGGED
11 hours agoCharlie Kirk: How to Beat the Woke and Save the West
16.3K70 -
11:09
Adam Does Movies
16 hours ago $0.03 earnedThe Acolyte Episode 2 - The Jedi Are INCREDIBLY STUPID! - Spoilers!
42.5K24 -
7:49
America Uncovered
15 hours ago $0.11 earnedSupreme Court Rules on Bump Stock Ban
28K36 -
58:59
Clownfish TV
20 hours agoBlack Myth: Wukong BLACKMAIL?! More Game Industry Layoffs! | CTRL+STREAM+DEL Livestream #06
32.7K5 -
15:24
TENET Media
20 hours ago $0.25 earnedMorals Vs Principles | Tim Pool
37.8K36 -
12:56
Melonie Mac
17 hours agoA New Low for Star Wars the Acolyte
21.2K28